Theratechnologies Inc.THTXNASDAQ
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank77
3Y CAGR-38.7%
5Y CAGR-4.7%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
-38.7%/yr
Quarterly compound
5Y CAGR
-4.7%/yr
Recent deceleration
Percentile
P77
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q2 2025 | 15.14% |
| Q1 2025 | -11.59% |
| Q4 2024 | 30.79% |
| Q3 2024 | -2.15% |
| Q2 2024 | 0.00% |
| Q1 2024 | -9.82% |
| Q4 2023 | 0.47% |
| Q3 2023 | 2.38% |
| Q2 2023 | -9.51% |
| Q1 2023 | -4.24% |
| Q4 2022 | -6.72% |
| Q3 2022 | -37.54% |
| Q2 2022 | 65.86% |
| Q1 2022 | 3.79% |
| Q4 2021 | 3.90% |
| Q3 2021 | 4.68% |
| Q2 2021 | 10.96% |
| Q1 2021 | -0.68% |
| Q4 2020 | 0.65% |
| Q3 2020 | -8.67% |
| Q2 2020 | 19.21% |
| Q1 2020 | -18.30% |
| Q4 2019 | 33.94% |
| Q3 2019 | -6.80% |
| Q2 2019 | 25.73% |
| Q1 2019 | -11.04% |
| Q4 2018 | 17.34% |
| Q3 2018 | -7.81% |
| Q2 2018 | 11.05% |
| Q1 2018 | -3.59% |
| Q4 2017 | 8.25% |
| Q3 2017 | 0.37% |
| Q2 2017 | 82.26% |
| Q1 2017 | 6.46% |
| Q4 2016 | -5.82% |
| Q3 2016 | 12.37% |
| Q2 2016 | -7.98% |
| Q1 2016 | -10.31% |
| Q4 2015 | 24.40% |
| Q3 2015 | 18.98% |